omega-n-methylarginine has been researched along with somatostatin in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (somatostatin) | Trials (somatostatin) | Recent Studies (post-2010) (somatostatin) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 29 | 0 | 11 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | somatostatin (IC50) |
|---|---|---|---|
| Somatostatin receptor type 5 | Mus musculus (house mouse) | 0.0001 | |
| Protein-lysine 6-oxidase | Homo sapiens (human) | 0.01 | |
| Somatostatin receptor type 1 | Homo sapiens (human) | 0.0012 | |
| Somatostatin receptor type 1 | Mus musculus (house mouse) | 0.0001 | |
| Somatostatin receptor type 2 | Homo sapiens (human) | 0.0007 | |
| Somatostatin receptor type 2 | Mus musculus (house mouse) | 0.0002 | |
| Somatostatin receptor type 3 | Mus musculus (house mouse) | 0.0001 | |
| Somatostatin receptor type 5 | Rattus norvegicus (Norway rat) | 0.0009 | |
| Somatostatin receptor type 4 | Homo sapiens (human) | 0.0012 | |
| Somatostatin receptor type 3 | Homo sapiens (human) | 0.002 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 2 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.006 | |
| Somatostatin receptor type 5 | Homo sapiens (human) | 0.003 | |
| Somatostatin receptor type 4 | Mus musculus (house mouse) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
1 other study(ies) available for omega-n-methylarginine and somatostatin
| Article | Year |
|---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |